OPTUS Pharmaceutical Statistics

Total Valuation

OPTUS Pharmaceutical has a market cap or net worth of KRW 112.91 billion. The enterprise value is 47.06 billion.

Market Cap	112.91B
Enterprise Value	47.06B

Important Dates

The next estimated earnings date is Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

OPTUS Pharmaceutical has 16.15 million shares outstanding. The number of shares has decreased by -1.44% in one year.

Shares Outstanding	16.15M
Shares Change (YoY)	-1.44%
Shares Change (QoQ)	+0.08%
Owned by Insiders (%)	0.80%
Owned by Institutions (%)	5.73%
Float	9.52M

Valuation Ratios

The trailing PE ratio is 10.39.

PE Ratio	10.39
Forward PE	n/a
PS Ratio	1.37
PB Ratio	0.78
P/FCF Ratio	10.20
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.84, with an EV/FCF ratio of 4.25.

EV / Earnings	4.59
EV / Sales	0.61
EV / EBITDA	3.84
EV / EBIT	5.68
EV / FCF	4.25

Financial Position

The company has a current ratio of 7.26, with a Debt / Equity ratio of 0.01.

Current Ratio	7.26
Quick Ratio	6.16
Debt / Equity	0.01
Debt / EBITDA	0.15
Debt / FCF	0.16
Interest Coverage	74.39

Financial Efficiency

Return on equity (ROE) is 7.71% and return on invested capital (ROIC) is 3.83%.

Return on Equity (ROE)	7.71%
Return on Assets (ROA)	3.54%
Return on Capital (ROIC)	3.83%
Revenue Per Employee	489.25M
Profits Per Employee	64.45M
Employee Count	159
Asset Turnover	0.53
Inventory Turnover	2.67

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +43.53% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+43.53%
50-Day Moving Average	6,941.40
200-Day Moving Average	6,354.90
Relative Strength Index (RSI)	50.91
Average Volume (20 Days)	261,417

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, OPTUS Pharmaceutical had revenue of KRW 77.79 billion and earned 10.25 billion in profits. Earnings per share was 672.46.

Revenue	77.79B
Gross Profit	43.02B
Operating Income	8.29B
Pretax Income	12.29B
Net Income	10.25B
EBITDA	12.25B
EBIT	8.29B
Earnings Per Share (EPS)	672.46

Full Income Statement

Balance Sheet

The company has 67.66 billion in cash and 1.81 billion in debt, giving a net cash position of 65.85 billion or 4,076.39 per share.

Cash & Cash Equivalents	67.66B
Total Debt	1.81B
Net Cash	65.85B
Net Cash Per Share	4,076.39
Equity (Book Value)	137.73B
Book Value Per Share	9,017.05
Working Capital	79.83B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 13.41 billion and capital expenditures -2.34 billion, giving a free cash flow of 11.07 billion.

Operating Cash Flow	13.41B
Capital Expenditures	-2.34B
Free Cash Flow	11.07B
FCF Per Share	685.59

Full Cash Flow Statement

Margins

Gross margin is 55.30%, with operating and profit margins of 10.65% and 13.17%.

Gross Margin	55.30%
Operating Margin	10.65%
Pretax Margin	15.80%
Profit Margin	13.17%
EBITDA Margin	15.74%
EBIT Margin	10.65%
FCF Margin	14.24%

Dividends & Yields

OPTUS Pharmaceutical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	14.89%
Buyback Yield	1.44%
Shareholder Yield	1.44%
Earnings Yield	9.62%
FCF Yield	9.81%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

OPTUS Pharmaceutical has an Altman Z-Score of 5.91.

Altman Z-Score	5.91
Piotroski F-Score	n/a